---
document_datetime: 2023-09-21 21:07:52
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/camcevi-epar-all-authorised-presentations_en.pdf
document_name: camcevi-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.6437972
conversion_datetime: 2025-12-25 04:35:01.454517
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form                        | Route of Administration   | Immediate Packaging        | Pack size                                                    |
|------------------|-------------------|------------|--------------------------------------------|---------------------------|----------------------------|--------------------------------------------------------------|
| EU/1/22/1647/001 | Camcevi           | 42 mg      | Prolonged-release suspension for injection | Subcutaneous use          | pre-filled syringe (glass) | 1 pre-filled syringe + 1 needle + 1 needle protection device |